Axsome Therapeutics, Inc.AXSMNASDAQ
Loading
Year-over-year operating income growth rate
Latest
36.17%
↑ 224% vs avg
Percentile
P95
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
-29.25%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 36.17% |
| Q3 2025 | -25.59% |
| Q2 2025 | 35.57% |
| Q1 2025 | 21.53% |
| Q4 2024 | -15.96% |
| Q3 2024 | 19.76% |
| Q2 2024 | -16.01% |
| Q1 2024 | 31.54% |
| Q4 2023 | -58.20% |
| Q3 2023 | 4.51% |
| Q2 2023 | -920.66% |
| Q1 2023 | 89.36% |
| Q4 2022 | -41.27% |
| Q3 2022 | -8.25% |
| Q2 2022 | -2.33% |
| Q1 2022 | -17.42% |
| Q4 2021 | 2.39% |
| Q3 2021 | -8.30% |
| Q2 2021 | -10.79% |
| Q1 2021 | -0.36% |
| Q4 2020 | -31.32% |
| Q3 2020 | -18.83% |
| Q2 2020 | 45.28% |
| Q1 2020 | -33.01% |
| Q4 2019 | -28.93% |
| Q3 2019 | -40.89% |
| Q2 2019 | -29.04% |
| Q1 2019 | -10.28% |
| Q4 2018 | -14.64% |
| Q3 2018 | -3.18% |
| Q2 2018 | -11.54% |
| Q1 2018 | -11.16% |
| Q4 2017 | -2.33% |
| Q3 2017 | 6.72% |
| Q2 2017 | 12.01% |
| Q1 2017 | -0.61% |
| Q4 2016 | -5.80% |
| Q3 2016 | -5.57% |
| Q2 2016 | -16.05% |
| Q1 2016 | -86.49% |